Skip to content

The randomized, double-blind clinical study about acupoint sticking therapy for chronic insomnia

The randomized, double-blind clinical study about acupoint sticking therapy for chronic insomnia

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-INR-16009783
Enrollment
Unknown
Registered
2016-11-08
Start date
2017-07-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Insomnia

Interventions

treatment group:Anmian stickers
control group: Blank stickers

Sponsors

Yueyang Integrative Medicine Hospital Affiliated to Shanghai University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1) Meet the sleep disorder international classification (ICSD - 3) diagnostic criteria of chronic insomnia; 2) Meet the Traditional Chinese Medicine standard of Liver-stagnation and Spleen-deficiency Syndrome; 3) Patient long-term used conventional medicine and the effect is not good; 4) Patients aged 18 to 60 years old.

Exclusion criteria

Exclusion criteria: 1) Patients with severe heart,liver, kidney damage, blood, respiratory disease and severe mental illness; 2) Patients have liver and AIDS infectious diseases or severe injury has not recovered; 3) Patients with severe digestive system diseases and severe malnutrition; 4) Women during pregnancy or lactation; 5) Not suitable for sticking the healer.

Design outcomes

Primary

MeasureTime frame
Pittsburgh Sleep Quality Index;

Secondary

MeasureTime frame
Insomnia Severity Index;TCM Syndromes Scale;actigraphy;

Countries

China

Contacts

Public ContactChen Yunfei

Yueyang Integrative Medicine Hospital Affiliated to Shanghai University of Traditional Chinese Medicine

icyf1968@126.com+86 13917922206

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026